Diastolic heart dysfunction, increased pulmonary capillary wedge pressure and impaired exercise tolerance in patients with systemic sclerosis

Kardiologia Polska

Volumn 69, Issue 3, 2011, Pages 243-249

  Płazak, Wojciech ^a   Gryga, Krzysztof ^a   Sznajd, Jan ^a   Tomkiewicz Paja̧k, Lidia ^a   Suchoń, Elzbieta ^a   Wilisowska, Joanna ^a   Musiał, Jacek ^a   Podolec, Piotr ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Cardiopulmonary exercise test; Diastolic dysfunction; Pulmonary capillary wedge pressure; Systemic sclerosis

Indexed keywords

CARBON DIOXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DIASTOLIC HEART FAILURE; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HUMAN; MALE; OXYGEN CONSUMPTION; PROGNOSIS; PULMONARY ARTERY OCCLUSION PRESSURE; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS;

EID: 79955390008     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Paulus WJ, Tschope C, Sanderson J. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J, 2007; 28: 2539-2550. (Pubitemid 47614269)
2. Nagueh SF, Middleton K, Kopelen H et al. Doppler tissue imaging: a noninvasive technique for the evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol, 1997, 30: 1527-1533. (Pubitemid 27486472)
3. Bruch C, Schmermund A, Bartel T et al. Tissue Doppler imaging: a new technique for assessment of pseudonormalization of the mitral inflow pattern. Echocardiography, 2000, 17: 539-546.
4. Wasserman K, Hansen JE, Sue DY et al. Principles of exercise testing and interpretation. Lea and Febige, Philadelphia 1994.
5. Braun-Falco O, Plewig G, Wolff HH et al. Diseases of connective tissue, systemic sclerosis. In: Braun-Falco O eds. Dermatology. Springer- Verlag, Berlin 2000: 789.
6. Plazak W, Zabinska-Plazak E, Wojas-Pelc A et al. Heart structure and function in systemic sclerosis. Eur J Dermatol, 2002; 12: 257-262. (Pubitemid 34454654)
7. Karassa FB, Ioannidis JP. Mortality in systemic sclerosis. Clin Exp Rheumatol, 2008; 26: S85-S93.
8. Kostis JB, Seibold JR, Turkevich D et al. Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med, 1988, 84: 1007-1017.
9. Wynn J, Fineberg N, Matzer L et al. Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. Am Heart J, 1985; 110: 123-127. (Pubitemid 16119691)
10. Weber KT, Kinasewitz GT, Janicki JS et al. Oxygen utilization and ventilation during exercise in patients with chronic heart failure. Circulation, 1982; 65: 1213-1223. (Pubitemid 12105109)
11. Yancy CW, Lopatin M, Stevenson LW et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function. J Am Coll Cardiol, 2006; 47: 76-84.
12. Bhatia RS, Tu JV, Lee DS et al. Outcome of heart failure with preserved ejection fraction in a population-based study. New Engl J Med, 2006; 355: 260-269. (Pubitemid 44088349)
13. Aurigemma P. Diastolic heart failure: a common and lethal condition by any name. N Engl J Med, 2006; 355: 308-310.
14. Poanta L, Dadu R, Tiboc C et al. Systolic and diastolic function in patients with systemic sclerosis. Eur J Intern Med, 2009; 20: 378-382.
15. Ciurzynski M, Bienias P, Lichodziejewska B et al. Assessment of left and right ventricular diastolic function in patients with systemic sclerosis. Kardiol Pol, 2008; 66: 269-276.
16. Gaal J, Hegedus I, Devenyi K et al. Myocardial gallinum-67 citrate scintigraphy in patients with systemic sclerosis. Ann Rheum Dis, 1995; 54: 856-858.
17. Gustafsson R, Mannting F, Kazzam E et al. Cold-induced reversible myocardial ischaemia in systemic sclerosis. Lancet, 1989; 2: 475-479. (Pubitemid 19209144)
18. Hegedus I, Czirjak L. Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis. Clin Rheumatol, 1995; 14: 161-164.
19. Ferri C, Emdin M, Giuggioli D et al. Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. Br J Rheumatol, 1997; 36: 669-676.
20. Gurtner C, Werner RJ, Winten G et al. Early diagnosis of cardiac involvement systemic sclerosis by 123I-MIBG neurotransmitter scintigraphy. Nucl Med Commun, 1998, 19: 849-857. (Pubitemid 28526875)
21. Stollerman GH. Progressive systemic sclerosis (diffuse scleroderma). In: Braunwald E ed. Heart disease. A textbook of cardiovascular medicine. W.B. Saunders Company, Philadelphia 1992: 1737.
22. Garcia-Fernandez MA, Azevedo J, Moreno M et al. Regional diastolic function in ischemic heart disease using pulsed wave Doppler tissue imaging. Eur Heart J, 1999; 20: 496-505. (Pubitemid 29149949)
23. Morelli S, Ferrante L, Sgreccia A et al. Pulmonary hypertension is associated with impaired exercise performance in patients with systemic sclerosis. Scand J Rheumatol, 2000; 29: 236-242. (Pubitemid 32015644)
24. Morelli S, Barbieri C, Sgreccia A et al. Relationship between cutaneous and pulmonary involvment in systemic sclerosis. J Rheumatol, 1997; 24: 81-85. (Pubitemid 27059862)
25. Steen V, Owens G, Fino G et al. Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheumatol, 1985; 28: 759-767.
26. Georgiev O, Shoskov P, Rashkov R. Longitudinal study of parameters of respiratory function test and blood gas analysis in patients with progressive systemic sclerosis. Vutr Boles, 2001; 33: 37-40. (Pubitemid 34272559)
27. de Oliveira NC, dos Santos Sabbag LM, Ueno LM et al. Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement. Scand J Rheumatol, 2007, 36: 458-461.
28. Sudduth CD, Strange C, Cook WR et al. Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. Am J Med, 1993; 95: 413-418. (Pubitemid 23303071)
29. Nanas S, Nanas J, Papazachou O et al. Resting lung function and hemodynamic parameters as predictors of exercise capacity in patients with chronic heart failure. Chest, 2003; 123: 1386-1393. (Pubitemid 36549754)
30. Kovacs G, Maier R, Aberer E et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med, 2009; 180: 881-886.
31. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation, 1991; 83: 1849-1865.
32. Weber KT, Sun Y, Tyagi SC et al. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol, 1994; 26: 279-292. (Pubitemid 24199288)
33. Weber KT. Extracellular matrix remodeling in heart failure. A role for de novo angiotensin II generation. Circulation, 1997, 96: 4065-4082.
34. Sun Y, Zhang JQ, Zhang J et al. Angiotensin II, transforming growth factor b1 and repair in the infarcted heart. J Mol Cell Cardiol, 1998; 30: 1559-1569. (Pubitemid 28418646)
35. Brilla CG, Janicki JS, Weber KT. Cardioreperative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation, 1991; 83: 1771-1779.